MilliporeSigma to build new $20 million, 12,000-square-foot lab in Switzerland
On the heels of opening a new laboratory in Shanghai last week, MilliporeSigma is continuing its construction push.
The Merck KGgA life science subsidiary announced Wednesday its intentions to build a new $20 million lab in Buchs, Switzerland to support its reference materials business. It’s estimated that the new facility will be completed in December 2021 and open in early 2022 and is expected to be 12,000 square feet.
Approximately two dozen new jobs will be created, MilliporeSigma said in a press release.
About 450 people work at MilliporeSigma’s Buchs site and the company considers it one of its most important research and development outfits. The location also serves as a main down-filling hub for MilliporeSigma and is only a short distance from Basel, Switzerland, which serves as a hub for several pharmas and biotechs in the country such as Novartis and Roche.
Last Friday, MilliporeSigma opened a new facility in Shanghai, the largest of its nine major collaboration centers. This followed the opening of an $11 million lab in Molsheim, France, and a $115 million investment from Merck KGaA in a Boston campus back in 2016.
Merck KGgA acquired Sigma-Aldrich for $17 billion in November 2015.